世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

2030年までの欧州ライフサイエンス・分析機器市場調査予測


Europe Life Science & Analytical Instruments Market Research Forecast to 2030

欧州のライフサイエンス・分析機器市場の2030年までの予測 市場概要 欧州のライフサイエンス・分析機器市場の成長は、さまざまな分野での分析機器需要の高まり、ライフサイエンス・分析機器市場における戦略的... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Market Research Future
マーケットリサーチフューチャー (MRFR)
2023年7月28日 US$5,250
ライセンス・価格情報・注文方法はこちら
105 英語

 

サマリー

欧州のライフサイエンス・分析機器市場の2030年までの予測
市場概要
欧州のライフサイエンス・分析機器市場の成長は、さまざまな分野での分析機器需要の高まり、ライフサイエンス・分析機器市場における戦略的イニシアチブの増加、院内感染(HAI)の流行拡大、未開拓の新興国などに起因している。しかし、熟練した専門家が少ないことが市場成長の妨げになると予想されている。
生命科学とは、生物の物理的・化学的構造、機能、発生、進化、生態を含む科学的研究である。ライフサイエンス分析装置は、病院、診断研究所、製薬会社などで使用されている。さらに、これらの機器は、医薬品開発に使用される材料の成分、含有量、品質の評価など、さまざまな目的に利用することができます。
生命科学とは、生物の物理的・化学的構造、機能、発生、進化、生態などを科学的に研究する学問である。ライフサイエンス分析装置は、病院、診断研究所、製薬会社などで使用されている。さらに、これらの機器は、医薬品開発に使用される材料の成分、含有量、品質の評価など、さまざまな目的に利用することができる。
市場区分
タイプ別に見ると、欧州のライフサイエンス&分析機器市場は、顕微鏡、クロマトグラフィー、細胞計数、分光学、PCR、電気泳動、フローサイトメトリー、次世代シーケンシング、遠心分離機、低温機器、その他に分けられる。
用途別では、欧州のライフサイエンス&分析機器市場は臨床・診断用途、研究用途、その他に分類される。
エンドユーザー別では、欧州ライフサイエンス・分析機器市場は製薬・バイオテクノロジー企業、病院・診断研究所、その他に分類される。
地域分析
欧州地域におけるバイオ医薬品セクターの活性化、増加する慢性疾患の治療法を見つけるための研究を推進する政府のイニシアティブの高まり、製薬メーカーの増加、経済の改善、一人当たりの可処分所得の高さ、医療支出の増加などの要因が、同地域の市場成長を促進している。さらに、研究開発活動の活発化とバイオ医薬品分野の発展も、欧州市場を牽引すると予想される。ドイツのような国々ではハイエンド技術が利用可能であり、先進的な研究を実施するために様々な公的機関や民間からの資金援助が増加していることが、市場の成長を促進している。欧州を拠点とする企業も、積極的な提携やM&Aによって市場を後押ししている。
主要企業
サーモフィッシャーサイエンティフィック社、メルクKGAA、BD社、アジレント・テクノロジー社、パーキンエルマー社




ページTOPに戻る


目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY 15
3.1 DATA MINING 15
3.2 SECONDARY RESEARCH 16
3.3 PRIMARY RESEARCH 17
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 18
3.5 FORECASTING TECHNIQUES 19
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 21
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 22
4 MARKET DYNAMICS 23
4.1 OVERVIEW 23
4.2 DRIVERS 24
4.2.1 RISING DEMAND FOR ANALYTICAL INSTRUMENTS IN DIFFERENT SECTORS 24
4.2.2 INCREASING STRATEGIC INITIATIVES IN THE LIFE SCIENCE AND ANALYTICAL INSTRUMENTS MARKET 24
4.2.3 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) 25
4.3 RESTRAINTS 26
4.3.1 DEARTH OF SKILLED PROFESSIONALS 26
4.4 OPPORTUNITIES 27
4.4.1 UNTAPPED EMERGING ECONOMIES 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 DISTRIBUTION & SALES 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 31
5.3.1 IMPACT ON SUPPLY CHAIN 31
5.3.2 IMPACT ON PRODUCTION 32
5.3.3 IMPACT ON MARKET PLAYERS 32
5.4 QUALITATIVE ANALYSIS OF CGT AND RNA TECHNOLOGIES IN GERMANY 32
5.4.1 OVERVIEW 32
5.4.2 INCREASING INVESTMENTS THROUGH PUBLIC AND PRIVATE SECTORS 32
5.4.3 EMERGING CGT AND RNA TECHNOLOGIES 33
6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE 34
6.1 OVERVIEW 34
6.2 SPECTROSCOPY 35
6.3 CHROMATOGRAPHY 36
6.4 PCR 37
6.5 MICROSCOPY 38
6.6 FLOW CYTOMETRY 39
6.7 NEXT GENERATION SEQUENCING 39
6.8 CENTRIFUGES 40
6.9 ELECTROPHORESIS 41
6.10 CELL COUNTING 41
6.11 CRYOGENIC INSTRUMENTS 42
6.12 OTHERS 43
7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION 44
7.1 OVERVIEW 44
7.2 RESEARCH APPLICATIONS 45
7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 45
7.4 OTHERS 46
8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER 47
8.1 OVERVIEW 47
8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 48
8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48
8.4 OTHERS 49
9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY 51
9.1 EUROPE 51
9.2 GERMANY 54
9.3 FRANCE 56
9.4 UK 57
9.5 ITALY 59
9.6 SWITZERLAND 60
9.7 SPAIN 62
9.8 REST OF EUROPE 63
10 COMPETITIVE LANDSCAPE 65
10.1 OVERVIEW 65
10.2 COMPETITIVE BENCHMARKING 66
10.3 MAJOR GROWTH STRATEGY IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.5 KEY DEVELOPMENT ANALYSIS 68
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 68
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
10.6.2 MERGER /ACQUISTION 68
10.7 FINANCIAL MATRIX 69
10.7.1 SALES (USD MILLION), 2021 69
10.7.2 R&D EXPENDITURE (USD MILLION), 2021 69
11 COMPANY PROFILES 70
11.1 THERMO FISHER SCIENTIFIC INC. 70
11.1.1 COMPANY OVERVIEW 70
11.1.2 FINANCIAL OVERVIEW 71
11.1.3 PRODUCTS OFFERED 72
11.1.4 KEY DEVELOPMENTS 72
11.1.5 SWOT ANALYSIS 73
11.1.6 KEY STRATEGIES 73
11.2 AGILENT TECHNOLOGIES INC. 74
11.2.1 COMPANY OVERVIEW 74
11.2.2 FINANCIAL OVERVIEW 75
11.2.3 PRODUCTS OFFERED 76
11.2.4 KEY DEVELOPMENTS 76
11.2.5 KEY STRATEGIES 76
11.3 QIAGEN 77
11.3.1 COMPANY OVERVIEW 77
11.3.2 FINANCIAL OVERVIEW 78
11.3.3 PRODUCTS OFFERED 78
11.3.4 KEY DEVELOPMENTS 79
11.3.5 SWOT ANALYSIS 79
11.3.6 KEY STRATEGIES 79
11.4 PERKINELMER INC. 80
11.4.1 COMPANY OVERVIEWS 80
11.4.2 FINANCIAL OVERVIEW 80
11.4.3 PRODUCTS OFFERED 81
11.4.4 KEY DEVELOPMENTS 81
11.4.5 KEY STRATEGIES 81
11.5 MERCK KGAA 82
11.5.1 COMPANY OVERVIEW 82
11.5.2 FINANCIAL OVERVIEW 83
11.5.3 PRODUCTS OFFERED 83
11.5.4 KEY DEVELOPMENTS 84
11.5.5 SWOT ANALYSIS 85
11.5.6 KEY STRATEGIES 85
11.6 EPPENDORF SE 86
11.6.1 COMPANY OVERVIEWS 86
11.6.2 FINANCIAL OVERVIEW 87
11.6.3 PRODUCTS OFFERED 88
11.6.4 KEY DEVELOPMENTS 88
11.6.5 KEY STRATEGIES 88
11.7 BRUKER 89
11.7.1 COMPANY OVERVIEW 89
11.7.2 FINANCIAL OVERVIEW 90
11.7.3 PRODUCTS OFFERED 91
11.7.4 KEY DEVELOPMENTS 92
11.7.5 SWOT ANALYSIS 92
11.7.6 KEY STRATEGIES 93
11.8 BD. 94
11.8.1 COMPANY OVERVIEW 94
11.8.2 FINANCIAL OVERVIEW 95
11.8.3 PRODUCTS OFFERED 95
11.8.4 KEY DEVELOPMENTS 96
11.8.5 KEY STRATEGIES 96
11.9 BIO-RAD LABORATORIES, INC. 97
11.9.1 COMPANY OVERVIEW 97
11.9.2 FINANCIAL OVERVIEW 98
11.9.3 PRODUCTS OFFERED 98
11.9.4 KEY DEVELOPMENTS 99
11.9.5 KEY STRATEGIES 99
11.10 HITACHI HIGH-TECHNOLOGIES CORPORATION 100
11.10.1 COMPANY OVERVIEW 100
11.10.2 FINANCIAL OVERVIEW 100
11.10.3 PRODUCTS OFFERED 101
11.10.4 KEY DEVELOPMENTS 101
11.10.5 SWOT ANALYSIS 102
11.10.6 KEY STRATEGIES 102
12 APPENDIX 103
12.1 REFERENCES 103
12.2 RELATED REPORTS 103
?

ページTOPに戻る



図表リスト

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17
TABLE 3 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 35
TABLE 4 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR SPECTROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 36
TABLE 5 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CHROMATOGRAPHY, BY COUNTRY, 2018?2030 (USD MILLION) 37
TABLE 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PCR, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR MICROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR FLOW CYTOMETRY, BY COUNTRY, 2018?2030 (USD MILLION) 39
TABLE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CENTRIFUGES, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR ELECTROPHORESIS, BY COUNTRY, 2018?2030 (USD MILLION) 41
TABLE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CELL COUNTING, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CRYOGENIC INSTRUMENTS, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 14 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 43
TABLE 15 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 44
TABLE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 45
TABLE 17 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CLINICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 18 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 19 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 47
TABLE 20 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018?2030 (USD MILLION) 48
TABLE 21 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018?2030 (USD MILLION) 49
TABLE 22 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 50
TABLE 23 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 52
TABLE 24 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 53
TABLE 25 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 53
TABLE 26 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 54
TABLE 27 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 54
TABLE 28 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 55
TABLE 29 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 55
TABLE 30 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 56
TABLE 31 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 56
TABLE 32 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 57
TABLE 33 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 57
TABLE 34 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 58
TABLE 35 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 58
TABLE 36 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 59
TABLE 37 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 59
TABLE 38 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 60
TABLE 39 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 60
TABLE 40 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 61
TABLE 41 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 61
TABLE 42 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 62
TABLE 43 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 62
TABLE 44 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 63
TABLE 45 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 63
TABLE 46 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 64
TABLE 47 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 64
TABLE 48 MAJOR PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 65
TABLE 49 MOST ACTIVE PLAYER IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
TABLE 50 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
TABLE 51 MERGER/ACQUISITION 68
TABLE 52 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 72
TABLE 53 AGILENT TECHNOLOGIES: PRODUCTS OFFERED 76
TABLE 54 QIAGEN: PRODUCTS OFFERED 78
TABLE 55 QIAGEN: KEY DEVELOPMENTS 79
TABLE 56 PERKINELMER INC.: PRODUCTS OFFERED 81
TABLE 57 MERCK KGAA: PRODUCTS OFFERED 83
TABLE 58 MERCK KGAA: KEY DEVELOPMENTS 84
TABLE 59 EPPENDORF SE: PRODUCTS OFFERED 88
TABLE 60 BRUKER: PRODUCTS OFFERED 91
TABLE 61 BRUKER: KEY DEVELOPMENTS 92
TABLE 62 BD.: PRODUCTS OFFERED 95
TABLE 63 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 98
TABLE 64 HITACHI HIGH-TECHNOLOGIES CORPORATION: PRODUCTS OFFERED 101

?

 

ページTOPに戻る


 

Summary

Europe Life Science & Analytical Instruments Market Research Forecast to 2030
Market Overview
The growth of the Europe life science & analytical instruments market is attributed to the rising demand for analytical instruments in different sectors, increasing strategic initiatives in the life science and analytical instruments market, the growing prevalence of Hospital-acquired Infections (HAIs), and untapped emerging economies. However, the dearth of skilled professionals is anticipated to hamper the market growth.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Market Segmentation
Based on the type, the Europe life science & analytical instruments market has been divided into microscopy, chromatography, cell counting, spectroscopy, PCR, electrophoresis, flow cytometry, next-generation sequencing, centrifuge instruments, cryogenic instruments, and others.
Based on application, the Europe life science & analytical instruments market has been categorized into clinical and diagnostics applications, research applications and others.
Based on end user, the Europe life science & analytical instruments market has been categorized into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others.
Regional Analysis
Factors such as a boost in the biopharmaceutical sector in the European region, rising government initiatives to promote research to find a cure to the increasing number of chronic diseases, a growing number of pharmaceutical manufacturers, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region. Furthermore, the growing R&D activities and the developing biopharmaceutical sector are also expected to drive the European market. The availability of high-end technologies in countries like Germany and growing funding from various public as well as private sources to conduct advanced research are fostering market growth. Europe-based companies are also boosting the market with active collaborations and mergers & acquisitions.
Major Players
Thermo Fisher Scientific Inc., Merck KGAA, BD., Agilent Technologies, Inc., and PerkinElmer Inc.




ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY 15
3.1 DATA MINING 15
3.2 SECONDARY RESEARCH 16
3.3 PRIMARY RESEARCH 17
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 18
3.5 FORECASTING TECHNIQUES 19
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 21
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 22
4 MARKET DYNAMICS 23
4.1 OVERVIEW 23
4.2 DRIVERS 24
4.2.1 RISING DEMAND FOR ANALYTICAL INSTRUMENTS IN DIFFERENT SECTORS 24
4.2.2 INCREASING STRATEGIC INITIATIVES IN THE LIFE SCIENCE AND ANALYTICAL INSTRUMENTS MARKET 24
4.2.3 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) 25
4.3 RESTRAINTS 26
4.3.1 DEARTH OF SKILLED PROFESSIONALS 26
4.4 OPPORTUNITIES 27
4.4.1 UNTAPPED EMERGING ECONOMIES 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 DISTRIBUTION & SALES 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 31
5.3.1 IMPACT ON SUPPLY CHAIN 31
5.3.2 IMPACT ON PRODUCTION 32
5.3.3 IMPACT ON MARKET PLAYERS 32
5.4 QUALITATIVE ANALYSIS OF CGT AND RNA TECHNOLOGIES IN GERMANY 32
5.4.1 OVERVIEW 32
5.4.2 INCREASING INVESTMENTS THROUGH PUBLIC AND PRIVATE SECTORS 32
5.4.3 EMERGING CGT AND RNA TECHNOLOGIES 33
6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE 34
6.1 OVERVIEW 34
6.2 SPECTROSCOPY 35
6.3 CHROMATOGRAPHY 36
6.4 PCR 37
6.5 MICROSCOPY 38
6.6 FLOW CYTOMETRY 39
6.7 NEXT GENERATION SEQUENCING 39
6.8 CENTRIFUGES 40
6.9 ELECTROPHORESIS 41
6.10 CELL COUNTING 41
6.11 CRYOGENIC INSTRUMENTS 42
6.12 OTHERS 43
7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION 44
7.1 OVERVIEW 44
7.2 RESEARCH APPLICATIONS 45
7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 45
7.4 OTHERS 46
8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER 47
8.1 OVERVIEW 47
8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 48
8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48
8.4 OTHERS 49
9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY 51
9.1 EUROPE 51
9.2 GERMANY 54
9.3 FRANCE 56
9.4 UK 57
9.5 ITALY 59
9.6 SWITZERLAND 60
9.7 SPAIN 62
9.8 REST OF EUROPE 63
10 COMPETITIVE LANDSCAPE 65
10.1 OVERVIEW 65
10.2 COMPETITIVE BENCHMARKING 66
10.3 MAJOR GROWTH STRATEGY IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.5 KEY DEVELOPMENT ANALYSIS 68
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 68
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
10.6.2 MERGER /ACQUISTION 68
10.7 FINANCIAL MATRIX 69
10.7.1 SALES (USD MILLION), 2021 69
10.7.2 R&D EXPENDITURE (USD MILLION), 2021 69
11 COMPANY PROFILES 70
11.1 THERMO FISHER SCIENTIFIC INC. 70
11.1.1 COMPANY OVERVIEW 70
11.1.2 FINANCIAL OVERVIEW 71
11.1.3 PRODUCTS OFFERED 72
11.1.4 KEY DEVELOPMENTS 72
11.1.5 SWOT ANALYSIS 73
11.1.6 KEY STRATEGIES 73
11.2 AGILENT TECHNOLOGIES INC. 74
11.2.1 COMPANY OVERVIEW 74
11.2.2 FINANCIAL OVERVIEW 75
11.2.3 PRODUCTS OFFERED 76
11.2.4 KEY DEVELOPMENTS 76
11.2.5 KEY STRATEGIES 76
11.3 QIAGEN 77
11.3.1 COMPANY OVERVIEW 77
11.3.2 FINANCIAL OVERVIEW 78
11.3.3 PRODUCTS OFFERED 78
11.3.4 KEY DEVELOPMENTS 79
11.3.5 SWOT ANALYSIS 79
11.3.6 KEY STRATEGIES 79
11.4 PERKINELMER INC. 80
11.4.1 COMPANY OVERVIEWS 80
11.4.2 FINANCIAL OVERVIEW 80
11.4.3 PRODUCTS OFFERED 81
11.4.4 KEY DEVELOPMENTS 81
11.4.5 KEY STRATEGIES 81
11.5 MERCK KGAA 82
11.5.1 COMPANY OVERVIEW 82
11.5.2 FINANCIAL OVERVIEW 83
11.5.3 PRODUCTS OFFERED 83
11.5.4 KEY DEVELOPMENTS 84
11.5.5 SWOT ANALYSIS 85
11.5.6 KEY STRATEGIES 85
11.6 EPPENDORF SE 86
11.6.1 COMPANY OVERVIEWS 86
11.6.2 FINANCIAL OVERVIEW 87
11.6.3 PRODUCTS OFFERED 88
11.6.4 KEY DEVELOPMENTS 88
11.6.5 KEY STRATEGIES 88
11.7 BRUKER 89
11.7.1 COMPANY OVERVIEW 89
11.7.2 FINANCIAL OVERVIEW 90
11.7.3 PRODUCTS OFFERED 91
11.7.4 KEY DEVELOPMENTS 92
11.7.5 SWOT ANALYSIS 92
11.7.6 KEY STRATEGIES 93
11.8 BD. 94
11.8.1 COMPANY OVERVIEW 94
11.8.2 FINANCIAL OVERVIEW 95
11.8.3 PRODUCTS OFFERED 95
11.8.4 KEY DEVELOPMENTS 96
11.8.5 KEY STRATEGIES 96
11.9 BIO-RAD LABORATORIES, INC. 97
11.9.1 COMPANY OVERVIEW 97
11.9.2 FINANCIAL OVERVIEW 98
11.9.3 PRODUCTS OFFERED 98
11.9.4 KEY DEVELOPMENTS 99
11.9.5 KEY STRATEGIES 99
11.10 HITACHI HIGH-TECHNOLOGIES CORPORATION 100
11.10.1 COMPANY OVERVIEW 100
11.10.2 FINANCIAL OVERVIEW 100
11.10.3 PRODUCTS OFFERED 101
11.10.4 KEY DEVELOPMENTS 101
11.10.5 SWOT ANALYSIS 102
11.10.6 KEY STRATEGIES 102
12 APPENDIX 103
12.1 REFERENCES 103
12.2 RELATED REPORTS 103
?

ページTOPに戻る



List of Tables/Graphs

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17
TABLE 3 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 35
TABLE 4 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR SPECTROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 36
TABLE 5 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CHROMATOGRAPHY, BY COUNTRY, 2018?2030 (USD MILLION) 37
TABLE 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PCR, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR MICROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR FLOW CYTOMETRY, BY COUNTRY, 2018?2030 (USD MILLION) 39
TABLE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CENTRIFUGES, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR ELECTROPHORESIS, BY COUNTRY, 2018?2030 (USD MILLION) 41
TABLE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CELL COUNTING, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CRYOGENIC INSTRUMENTS, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 14 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 43
TABLE 15 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 44
TABLE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 45
TABLE 17 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CLINICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 18 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 19 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 47
TABLE 20 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018?2030 (USD MILLION) 48
TABLE 21 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018?2030 (USD MILLION) 49
TABLE 22 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 50
TABLE 23 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 52
TABLE 24 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 53
TABLE 25 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 53
TABLE 26 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 54
TABLE 27 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 54
TABLE 28 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 55
TABLE 29 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 55
TABLE 30 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 56
TABLE 31 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 56
TABLE 32 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 57
TABLE 33 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 57
TABLE 34 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 58
TABLE 35 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 58
TABLE 36 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 59
TABLE 37 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 59
TABLE 38 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 60
TABLE 39 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 60
TABLE 40 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 61
TABLE 41 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 61
TABLE 42 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 62
TABLE 43 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 62
TABLE 44 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 63
TABLE 45 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 63
TABLE 46 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 64
TABLE 47 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 64
TABLE 48 MAJOR PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 65
TABLE 49 MOST ACTIVE PLAYER IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
TABLE 50 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
TABLE 51 MERGER/ACQUISITION 68
TABLE 52 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 72
TABLE 53 AGILENT TECHNOLOGIES: PRODUCTS OFFERED 76
TABLE 54 QIAGEN: PRODUCTS OFFERED 78
TABLE 55 QIAGEN: KEY DEVELOPMENTS 79
TABLE 56 PERKINELMER INC.: PRODUCTS OFFERED 81
TABLE 57 MERCK KGAA: PRODUCTS OFFERED 83
TABLE 58 MERCK KGAA: KEY DEVELOPMENTS 84
TABLE 59 EPPENDORF SE: PRODUCTS OFFERED 88
TABLE 60 BRUKER: PRODUCTS OFFERED 91
TABLE 61 BRUKER: KEY DEVELOPMENTS 92
TABLE 62 BD.: PRODUCTS OFFERED 95
TABLE 63 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 98
TABLE 64 HITACHI HIGH-TECHNOLOGIES CORPORATION: PRODUCTS OFFERED 101

?

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Market Research Future 社の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Market Research Future社はどのような調査会社ですか?


マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。   下記分野については、分野毎に専... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/04 10:27

162.47 円

175.74 円

209.86 円

ページTOPに戻る